nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP3A5—prostate cancer	0.106	0.357	CbGaD
Nicardipine—CYP2E1—prostate cancer	0.0731	0.245	CbGaD
Nicardipine—CYP2C19—prostate cancer	0.0724	0.243	CbGaD
Nicardipine—CYP3A4—prostate cancer	0.046	0.155	CbGaD
Nicardipine—CYP2C8—Nilutamide—prostate cancer	0.0169	0.0431	CbGbCtD
Nicardipine—CYP3A5—Flutamide—prostate cancer	0.0146	0.0372	CbGbCtD
Nicardipine—CYP2C19—Nilutamide—prostate cancer	0.0142	0.0362	CbGbCtD
Nicardipine—CYP2C19—Bicalutamide—prostate cancer	0.0142	0.0362	CbGbCtD
Nicardipine—CYP2C8—Abiraterone—prostate cancer	0.014	0.0357	CbGbCtD
Nicardipine—CYP2E1—Estrone—prostate cancer	0.0136	0.0346	CbGbCtD
Nicardipine—CYP2B6—Estrone—prostate cancer	0.0134	0.0341	CbGbCtD
Nicardipine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0131	0.0333	CbGbCtD
Nicardipine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0119	0.0304	CbGbCtD
Nicardipine—CYP2C9—Nilutamide—prostate cancer	0.0118	0.0301	CbGbCtD
Nicardipine—CYP2C9—Bicalutamide—prostate cancer	0.0118	0.0301	CbGbCtD
Nicardipine—CYP2C19—Flutamide—prostate cancer	0.0118	0.03	CbGbCtD
Nicardipine—CYP2D6—Bicalutamide—prostate cancer	0.0108	0.0275	CbGbCtD
Nicardipine—CYP3A5—Cabazitaxel—prostate cancer	0.0108	0.0275	CbGbCtD
Nicardipine—ABCB1—Estramustine—prostate cancer	0.0107	0.0271	CbGbCtD
Nicardipine—CYP3A5—Estrone—prostate cancer	0.0105	0.0269	CbGbCtD
Nicardipine—CYP2C8—Cabazitaxel—prostate cancer	0.0104	0.0264	CbGbCtD
Nicardipine—ADRA1B—vas deferens—prostate cancer	0.00983	0.174	CbGeAlD
Nicardipine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00904	0.023	CbGbCtD
Nicardipine—CYP2D6—Abiraterone—prostate cancer	0.00895	0.0228	CbGbCtD
Nicardipine—CYP2E1—Mitoxantrone—prostate cancer	0.00807	0.0206	CbGbCtD
Nicardipine—CYP2C9—Estrone—prostate cancer	0.00707	0.018	CbGbCtD
Nicardipine—ABCB1—Cabazitaxel—prostate cancer	0.00702	0.0179	CbGbCtD
Nicardipine—CYP3A4—Bicalutamide—prostate cancer	0.00686	0.0175	CbGbCtD
Nicardipine—ABCB1—Estrone—prostate cancer	0.00686	0.0175	CbGbCtD
Nicardipine—CYP3A4—Estramustine—prostate cancer	0.00638	0.0163	CbGbCtD
Nicardipine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00612	0.0156	CbGbCtD
Nicardipine—CYP3A5—Estradiol—prostate cancer	0.00606	0.0154	CbGbCtD
Nicardipine—CYP2C8—Estradiol—prostate cancer	0.00582	0.0148	CbGbCtD
Nicardipine—CYP3A4—Flutamide—prostate cancer	0.00569	0.0145	CbGbCtD
Nicardipine—CYP3A4—Abiraterone—prostate cancer	0.00569	0.0145	CbGbCtD
Nicardipine—CYP2C9—Capecitabine—prostate cancer	0.00536	0.0137	CbGbCtD
Nicardipine—CYP2E1—Etoposide—prostate cancer	0.00509	0.013	CbGbCtD
Nicardipine—CYP2C19—Estradiol—prostate cancer	0.00489	0.0125	CbGbCtD
Nicardipine—CHRM3—ureter—prostate cancer	0.0046	0.0814	CbGeAlD
Nicardipine—ABCB1—Conjugated Estrogens—prostate cancer	0.00449	0.0114	CbGbCtD
Nicardipine—CYP3A4—Cabazitaxel—prostate cancer	0.00421	0.0107	CbGbCtD
Nicardipine—CYP2C19—Prednisone—prostate cancer	0.0042	0.0107	CbGbCtD
Nicardipine—CYP3A4—Estrone—prostate cancer	0.00411	0.0105	CbGbCtD
Nicardipine—ABCB1—Mitoxantrone—prostate cancer	0.00408	0.0104	CbGbCtD
Nicardipine—CYP2C9—Estradiol—prostate cancer	0.00406	0.0104	CbGbCtD
Nicardipine—CYP3A5—Etoposide—prostate cancer	0.00395	0.0101	CbGbCtD
Nicardipine—ABCB1—Estradiol—prostate cancer	0.00394	0.01	CbGbCtD
Nicardipine—CYP2C8—Etoposide—prostate cancer	0.0038	0.00969	CbGbCtD
Nicardipine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00367	0.00934	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—prostate cancer	0.00362	0.00922	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—prostate cancer	0.00342	0.00873	CbGbCtD
Nicardipine—ABCB1—Prednisone—prostate cancer	0.00339	0.00864	CbGbCtD
Nicardipine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00269	0.00686	CbGbCtD
Nicardipine—ABCB1—Etoposide—prostate cancer	0.00257	0.00656	CbGbCtD
Nicardipine—CYP3A4—Mitoxantrone—prostate cancer	0.00245	0.00623	CbGbCtD
Nicardipine—CYP3A4—Estradiol—prostate cancer	0.00236	0.00602	CbGbCtD
Nicardipine—ABCB1—Docetaxel—prostate cancer	0.00236	0.006	CbGbCtD
Nicardipine—CALM2—semen—prostate cancer	0.0021	0.0371	CbGeAlD
Nicardipine—CALM1—semen—prostate cancer	0.00209	0.0369	CbGeAlD
Nicardipine—CYP3A4—Prednisone—prostate cancer	0.00203	0.00518	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—prostate cancer	0.00176	0.00447	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—prostate cancer	0.00165	0.00422	CbGbCtD
Nicardipine—PDE1B—prostate gland—prostate cancer	0.0016	0.0283	CbGeAlD
Nicardipine—CYP3A4—Etoposide—prostate cancer	0.00154	0.00393	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—prostate cancer	0.00141	0.0036	CbGbCtD
Nicardipine—CYP2C19—urine—prostate cancer	0.00139	0.0246	CbGeAlD
Nicardipine—PDE1A—prostate gland—prostate cancer	0.00134	0.0237	CbGeAlD
Nicardipine—CYP2C9—urine—prostate cancer	0.00108	0.0191	CbGeAlD
Nicardipine—CYP3A4—Doxorubicin—prostate cancer	0.00105	0.00268	CbGbCtD
Nicardipine—CYP2E1—urine—prostate cancer	0.00102	0.0181	CbGeAlD
Nicardipine—CACNB2—prostate gland—prostate cancer	0.00099	0.0175	CbGeAlD
Nicardipine—CACNA2D1—prostate gland—prostate cancer	0.00093	0.0164	CbGeAlD
Nicardipine—PDE1A—renal system—prostate cancer	0.000916	0.0162	CbGeAlD
Nicardipine—CACNA1D—prostate gland—prostate cancer	0.000866	0.0153	CbGeAlD
Nicardipine—ADRA1D—prostate gland—prostate cancer	0.000858	0.0152	CbGeAlD
Nicardipine—CYP3A4—urine—prostate cancer	0.000822	0.0145	CbGeAlD
Nicardipine—CYP2D6—urine—prostate cancer	0.000809	0.0143	CbGeAlD
Nicardipine—CACNA1C—prostate gland—prostate cancer	0.000799	0.0141	CbGeAlD
Nicardipine—PDE1B—testis—prostate cancer	0.000706	0.0125	CbGeAlD
Nicardipine—CHRM5—epithelium—prostate cancer	0.000706	0.0125	CbGeAlD
Nicardipine—CALM3—prostate gland—prostate cancer	0.000669	0.0118	CbGeAlD
Nicardipine—CHRM2—prostate gland—prostate cancer	0.000659	0.0117	CbGeAlD
Nicardipine—ADRA1D—epithelium—prostate cancer	0.000631	0.0111	CbGeAlD
Nicardipine—CHRM1—prostate gland—prostate cancer	0.0006	0.0106	CbGeAlD
Nicardipine—ADRA1B—renal system—prostate cancer	0.000598	0.0106	CbGeAlD
Nicardipine—PDE1A—testis—prostate cancer	0.000592	0.0105	CbGeAlD
Nicardipine—ADRA1D—urethra—prostate cancer	0.000575	0.0102	CbGeAlD
Nicardipine—CALM3—seminal vesicle—prostate cancer	0.000566	0.01	CbGeAlD
Nicardipine—CHRM4—testis—prostate cancer	0.000541	0.00957	CbGeAlD
Nicardipine—CHRM3—prostate gland—prostate cancer	0.000537	0.00949	CbGeAlD
Nicardipine—CALM2—prostate gland—prostate cancer	0.000526	0.00929	CbGeAlD
Nicardipine—CALM1—prostate gland—prostate cancer	0.000523	0.00925	CbGeAlD
Nicardipine—PDE1B—lymph node—prostate cancer	0.000512	0.00905	CbGeAlD
Nicardipine—ADRA1A—prostate gland—prostate cancer	0.000493	0.00871	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—prostate cancer	0.000479	0.00847	CbGeAlD
Nicardipine—CALM3—urethra—prostate cancer	0.000448	0.00792	CbGeAlD
Nicardipine—CALM2—seminal vesicle—prostate cancer	0.000445	0.00786	CbGeAlD
Nicardipine—CACNB2—testis—prostate cancer	0.000436	0.00771	CbGeAlD
Nicardipine—PDE1A—lymph node—prostate cancer	0.000429	0.00758	CbGeAlD
Nicardipine—CACNA2D1—testis—prostate cancer	0.00041	0.00724	CbGeAlD
Nicardipine—CYP3A5—prostate gland—prostate cancer	0.000393	0.00695	CbGeAlD
Nicardipine—CALM2—epithelium—prostate cancer	0.000386	0.00683	CbGeAlD
Nicardipine—CALM1—epithelium—prostate cancer	0.000384	0.0068	CbGeAlD
Nicardipine—CACNA1D—testis—prostate cancer	0.000381	0.00674	CbGeAlD
Nicardipine—CYP2E1—prostate gland—prostate cancer	0.000367	0.00648	CbGeAlD
Nicardipine—CHRM3—renal system—prostate cancer	0.000366	0.00647	CbGeAlD
Nicardipine—ADRA1A—epithelium—prostate cancer	0.000362	0.0064	CbGeAlD
Nicardipine—CHRM3—urethra—prostate cancer	0.000359	0.00635	CbGeAlD
Nicardipine—CALM2—renal system—prostate cancer	0.000358	0.00633	CbGeAlD
Nicardipine—Nimodipine—AHR—prostate cancer	0.000357	0.109	CrCbGaD
Nicardipine—CALM1—renal system—prostate cancer	0.000357	0.0063	CbGeAlD
Nicardipine—CACNA1C—testis—prostate cancer	0.000352	0.00622	CbGeAlD
Nicardipine—CALM2—urethra—prostate cancer	0.000352	0.00622	CbGeAlD
Nicardipine—CALM1—urethra—prostate cancer	0.00035	0.00619	CbGeAlD
Nicardipine—CALM3—bone marrow—prostate cancer	0.000345	0.0061	CbGeAlD
Nicardipine—ADRA1A—renal system—prostate cancer	0.000336	0.00594	CbGeAlD
Nicardipine—CACNB2—lymph node—prostate cancer	0.000316	0.00559	CbGeAlD
Nicardipine—CYP2E1—seminal vesicle—prostate cancer	0.00031	0.00548	CbGeAlD
Nicardipine—CACNA2D1—lymph node—prostate cancer	0.000297	0.00525	CbGeAlD
Nicardipine—CYP2C8—renal system—prostate cancer	0.000297	0.00525	CbGeAlD
Nicardipine—CALM3—testis—prostate cancer	0.000295	0.00521	CbGeAlD
Nicardipine—CACNA1D—lymph node—prostate cancer	0.000276	0.00489	CbGeAlD
Nicardipine—CALM2—bone marrow—prostate cancer	0.000271	0.00479	CbGeAlD
Nicardipine—CALM1—bone marrow—prostate cancer	0.00027	0.00477	CbGeAlD
Nicardipine—CYP3A5—renal system—prostate cancer	0.000268	0.00474	CbGeAlD
Nicardipine—CYP2B6—renal system—prostate cancer	0.000266	0.00471	CbGeAlD
Nicardipine—CACNA1C—lymph node—prostate cancer	0.000255	0.00451	CbGeAlD
Nicardipine—CYP2E1—renal system—prostate cancer	0.00025	0.00442	CbGeAlD
Nicardipine—CYP2E1—urethra—prostate cancer	0.000246	0.00434	CbGeAlD
Nicardipine—CHRM3—testis—prostate cancer	0.000237	0.00418	CbGeAlD
Nicardipine—CALM2—testis—prostate cancer	0.000232	0.00409	CbGeAlD
Nicardipine—CALM1—testis—prostate cancer	0.00023	0.00407	CbGeAlD
Nicardipine—Lercanidipine—CYP3A5—prostate cancer	0.000221	0.0676	CrCbGaD
Nicardipine—CALM3—lymph node—prostate cancer	0.000214	0.00378	CbGeAlD
Nicardipine—ABCB1—prostate gland—prostate cancer	0.000209	0.00369	CbGeAlD
Nicardipine—CYP3A4—renal system—prostate cancer	0.000201	0.00355	CbGeAlD
Nicardipine—CYP2D6—renal system—prostate cancer	0.000198	0.0035	CbGeAlD
Nicardipine—CYP2C8—testis—prostate cancer	0.000192	0.00339	CbGeAlD
Nicardipine—ABCB1—seminal vesicle—prostate cancer	0.000177	0.00312	CbGeAlD
Nicardipine—CYP2B6—testis—prostate cancer	0.000172	0.00304	CbGeAlD
Nicardipine—Nisoldipine—CYP3A5—prostate cancer	0.000169	0.0516	CrCbGaD
Nicardipine—CALM2—lymph node—prostate cancer	0.000168	0.00297	CbGeAlD
Nicardipine—CALM1—lymph node—prostate cancer	0.000167	0.00295	CbGeAlD
Nicardipine—Nimodipine—CYP3A5—prostate cancer	0.000163	0.0498	CrCbGaD
Nicardipine—CYP2E1—testis—prostate cancer	0.000162	0.00286	CbGeAlD
Nicardipine—Nitrendipine—CYP3A5—prostate cancer	0.000158	0.0483	CrCbGaD
Nicardipine—ABCB1—epithelium—prostate cancer	0.000153	0.00271	CbGeAlD
Nicardipine—Nilvadipine—CYP2A6—prostate cancer	0.000153	0.0467	CrCbGaD
Nicardipine—ABCB1—renal system—prostate cancer	0.000142	0.00252	CbGeAlD
Nicardipine—ABCB1—urethra—prostate cancer	0.00014	0.00247	CbGeAlD
Nicardipine—Amlodipine—CYP3A5—prostate cancer	0.000136	0.0415	CrCbGaD
Nicardipine—Amlodipine—CYP2A6—prostate cancer	0.000132	0.0402	CrCbGaD
Nicardipine—CYP2D6—testis—prostate cancer	0.000128	0.00226	CbGeAlD
Nicardipine—Felodipine—CYP3A5—prostate cancer	0.000126	0.0384	CrCbGaD
Nicardipine—Nifedipine—CYP3A5—prostate cancer	0.000122	0.0371	CrCbGaD
Nicardipine—Clevidipine—CYP2E1—prostate cancer	0.000121	0.037	CrCbGaD
Nicardipine—Clevidipine—CYP2C19—prostate cancer	0.00012	0.0366	CrCbGaD
Nicardipine—Nifedipine—CYP2A6—prostate cancer	0.000118	0.036	CrCbGaD
Nicardipine—Nilvadipine—CYP2E1—prostate cancer	0.000109	0.0332	CrCbGaD
Nicardipine—ABCB1—bone marrow—prostate cancer	0.000108	0.0019	CbGeAlD
Nicardipine—Nilvadipine—CYP2C19—prostate cancer	0.000108	0.0328	CrCbGaD
Nicardipine—Lercanidipine—CYP3A4—prostate cancer	9.58e-05	0.0293	CrCbGaD
Nicardipine—Amlodipine—CYP1A1—prostate cancer	9.23e-05	0.0282	CrCbGaD
Nicardipine—ABCB1—testis—prostate cancer	9.2e-05	0.00163	CbGeAlD
Nicardipine—Isradipine—CYP3A4—prostate cancer	8.66e-05	0.0265	CrCbGaD
Nicardipine—Nifedipine—CYP2E1—prostate cancer	8.36e-05	0.0255	CrCbGaD
Nicardipine—Nifedipine—CYP1A1—prostate cancer	8.25e-05	0.0252	CrCbGaD
Nicardipine—Clevidipine—CYP3A4—prostate cancer	7.63e-05	0.0233	CrCbGaD
Nicardipine—Nisoldipine—CYP3A4—prostate cancer	7.31e-05	0.0223	CrCbGaD
Nicardipine—Nimodipine—CYP3A4—prostate cancer	7.06e-05	0.0216	CrCbGaD
Nicardipine—Nitrendipine—CYP3A4—prostate cancer	6.84e-05	0.0209	CrCbGaD
Nicardipine—Nilvadipine—CYP3A4—prostate cancer	6.84e-05	0.0209	CrCbGaD
Nicardipine—ABCB1—lymph node—prostate cancer	6.67e-05	0.00118	CbGeAlD
Nicardipine—Amlodipine—CYP3A4—prostate cancer	5.89e-05	0.018	CrCbGaD
Nicardipine—Vertigo—Capecitabine—prostate cancer	5.68e-05	0.00046	CcSEcCtD
Nicardipine—Hypersensitivity—Mitoxantrone—prostate cancer	5.68e-05	0.00046	CcSEcCtD
Nicardipine—Syncope—Capecitabine—prostate cancer	5.67e-05	0.00046	CcSEcCtD
Nicardipine—Diarrhoea—Estradiol—prostate cancer	5.66e-05	0.000459	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—prostate cancer	5.63e-05	0.000457	CcSEcCtD
Nicardipine—Palpitations—Capecitabine—prostate cancer	5.58e-05	0.000453	CcSEcCtD
Nicardipine—Chest pain—Docetaxel—prostate cancer	5.56e-05	0.000451	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—prostate cancer	5.56e-05	0.000451	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—prostate cancer	5.56e-05	0.000451	CcSEcCtD
Nicardipine—Loss of consciousness—Capecitabine—prostate cancer	5.55e-05	0.00045	CcSEcCtD
Nicardipine—Asthenia—Mitoxantrone—prostate cancer	5.53e-05	0.000448	CcSEcCtD
Nicardipine—Pain—Etoposide—prostate cancer	5.48e-05	0.000445	CcSEcCtD
Nicardipine—Constipation—Etoposide—prostate cancer	5.48e-05	0.000445	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—prostate cancer	5.48e-05	0.000444	CcSEcCtD
Nicardipine—Dizziness—Estradiol—prostate cancer	5.47e-05	0.000444	CcSEcCtD
Nicardipine—Hypertension—Capecitabine—prostate cancer	5.46e-05	0.000442	CcSEcCtD
Nicardipine—Felodipine—CYP3A4—prostate cancer	5.44e-05	0.0166	CrCbGaD
Nicardipine—Dry mouth—Docetaxel—prostate cancer	5.43e-05	0.000441	CcSEcCtD
Nicardipine—Sweating—Epirubicin—prostate cancer	5.4e-05	0.000438	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—prostate cancer	5.4e-05	0.000438	CcSEcCtD
Nicardipine—Chest pain—Capecitabine—prostate cancer	5.38e-05	0.000436	CcSEcCtD
Nicardipine—Arthralgia—Capecitabine—prostate cancer	5.38e-05	0.000436	CcSEcCtD
Nicardipine—Myalgia—Capecitabine—prostate cancer	5.38e-05	0.000436	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—prostate cancer	5.37e-05	0.000436	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—prostate cancer	5.37e-05	0.000436	CcSEcCtD
Nicardipine—Anxiety—Capecitabine—prostate cancer	5.36e-05	0.000435	CcSEcCtD
Nicardipine—Oedema—Docetaxel—prostate cancer	5.33e-05	0.000432	CcSEcCtD
Nicardipine—Discomfort—Capecitabine—prostate cancer	5.31e-05	0.000431	CcSEcCtD
Nicardipine—Vision blurred—Prednisone—prostate cancer	5.3e-05	0.00043	CcSEcCtD
Nicardipine—Infection—Docetaxel—prostate cancer	5.29e-05	0.000429	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—prostate cancer	5.28e-05	0.000429	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—prostate cancer	5.28e-05	0.000428	CcSEcCtD
Nicardipine—Diarrhoea—Mitoxantrone—prostate cancer	5.27e-05	0.000428	CcSEcCtD
Nicardipine—Nifedipine—CYP3A4—prostate cancer	5.27e-05	0.0161	CrCbGaD
Nicardipine—Dry mouth—Capecitabine—prostate cancer	5.26e-05	0.000427	CcSEcCtD
Nicardipine—Vomiting—Estradiol—prostate cancer	5.26e-05	0.000426	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—prostate cancer	5.24e-05	0.000425	CcSEcCtD
Nicardipine—Shock—Docetaxel—prostate cancer	5.24e-05	0.000425	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisone—prostate cancer	5.22e-05	0.000424	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—prostate cancer	5.21e-05	0.000423	CcSEcCtD
Nicardipine—Rash—Estradiol—prostate cancer	5.21e-05	0.000423	CcSEcCtD
Nicardipine—Dermatitis—Estradiol—prostate cancer	5.21e-05	0.000422	CcSEcCtD
Nicardipine—Confusional state—Capecitabine—prostate cancer	5.2e-05	0.000422	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—prostate cancer	5.2e-05	0.000422	CcSEcCtD
Nicardipine—Headache—Estradiol—prostate cancer	5.18e-05	0.00042	CcSEcCtD
Nicardipine—Agitation—Prednisone—prostate cancer	5.17e-05	0.00042	CcSEcCtD
Nicardipine—Oedema—Capecitabine—prostate cancer	5.16e-05	0.000418	CcSEcCtD
Nicardipine—Infection—Capecitabine—prostate cancer	5.12e-05	0.000416	CcSEcCtD
Nicardipine—Malaise—Prednisone—prostate cancer	5.08e-05	0.000412	CcSEcCtD
Nicardipine—Shock—Capecitabine—prostate cancer	5.07e-05	0.000411	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—prostate cancer	5.07e-05	0.000411	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—prostate cancer	5.07e-05	0.000411	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—prostate cancer	5.07e-05	0.000411	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—prostate cancer	5.07e-05	0.000411	CcSEcCtD
Nicardipine—Vertigo—Prednisone—prostate cancer	5.06e-05	0.00041	CcSEcCtD
Nicardipine—Thrombocytopenia—Capecitabine—prostate cancer	5.05e-05	0.00041	CcSEcCtD
Nicardipine—Syncope—Prednisone—prostate cancer	5.05e-05	0.000409	CcSEcCtD
Nicardipine—Tachycardia—Capecitabine—prostate cancer	5.03e-05	0.000408	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—prostate cancer	5.03e-05	0.000408	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—prostate cancer	5e-05	0.000405	CcSEcCtD
Nicardipine—Hyperhidrosis—Capecitabine—prostate cancer	4.99e-05	0.000404	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—prostate cancer	4.98e-05	0.000404	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—prostate cancer	4.98e-05	0.000404	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—prostate cancer	4.97e-05	0.000403	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—prostate cancer	4.95e-05	0.000401	CcSEcCtD
Nicardipine—Nausea—Estradiol—prostate cancer	4.91e-05	0.000398	CcSEcCtD
Nicardipine—Vomiting—Mitoxantrone—prostate cancer	4.9e-05	0.000397	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—prostate cancer	4.89e-05	0.000397	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—prostate cancer	4.87e-05	0.000395	CcSEcCtD
Nicardipine—Hypertension—Prednisone—prostate cancer	4.86e-05	0.000394	CcSEcCtD
Nicardipine—Rash—Mitoxantrone—prostate cancer	4.86e-05	0.000394	CcSEcCtD
Nicardipine—Dermatitis—Mitoxantrone—prostate cancer	4.85e-05	0.000394	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.85e-05	0.000394	CcSEcCtD
Nicardipine—Headache—Mitoxantrone—prostate cancer	4.83e-05	0.000391	CcSEcCtD
Nicardipine—Hypotension—Capecitabine—prostate cancer	4.82e-05	0.000391	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—prostate cancer	4.82e-05	0.000391	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—prostate cancer	4.79e-05	0.000389	CcSEcCtD
Nicardipine—Myalgia—Prednisone—prostate cancer	4.79e-05	0.000389	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—prostate cancer	4.78e-05	0.000388	CcSEcCtD
Nicardipine—Anxiety—Prednisone—prostate cancer	4.77e-05	0.000387	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—prostate cancer	4.75e-05	0.000385	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—prostate cancer	4.73e-05	0.000384	CcSEcCtD
Nicardipine—Discomfort—Prednisone—prostate cancer	4.73e-05	0.000384	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—prostate cancer	4.72e-05	0.000383	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—prostate cancer	4.71e-05	0.000382	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.7e-05	0.000381	CcSEcCtD
Nicardipine—Flushing—Epirubicin—prostate cancer	4.69e-05	0.000381	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—prostate cancer	4.69e-05	0.00038	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—prostate cancer	4.69e-05	0.00038	CcSEcCtD
Nicardipine—Insomnia—Capecitabine—prostate cancer	4.66e-05	0.000378	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—prostate cancer	4.66e-05	0.000378	CcSEcCtD
Nicardipine—Paraesthesia—Capecitabine—prostate cancer	4.63e-05	0.000376	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—prostate cancer	4.61e-05	0.000374	CcSEcCtD
Nicardipine—Asthenia—Etoposide—prostate cancer	4.6e-05	0.000373	CcSEcCtD
Nicardipine—Dyspnoea—Capecitabine—prostate cancer	4.6e-05	0.000373	CcSEcCtD
Nicardipine—Oedema—Prednisone—prostate cancer	4.59e-05	0.000373	CcSEcCtD
Nicardipine—Nausea—Mitoxantrone—prostate cancer	4.58e-05	0.000371	CcSEcCtD
Nicardipine—Infection—Prednisone—prostate cancer	4.56e-05	0.00037	CcSEcCtD
Nicardipine—Constipation—Docetaxel—prostate cancer	4.55e-05	0.000369	CcSEcCtD
Nicardipine—Pain—Docetaxel—prostate cancer	4.55e-05	0.000369	CcSEcCtD
Nicardipine—Dyspepsia—Capecitabine—prostate cancer	4.54e-05	0.000368	CcSEcCtD
Nicardipine—Shock—Prednisone—prostate cancer	4.52e-05	0.000367	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—prostate cancer	4.51e-05	0.000366	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—prostate cancer	4.48e-05	0.000364	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisone—prostate cancer	4.44e-05	0.00036	CcSEcCtD
Nicardipine—Pain—Capecitabine—prostate cancer	4.41e-05	0.000358	CcSEcCtD
Nicardipine—Constipation—Capecitabine—prostate cancer	4.41e-05	0.000358	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—prostate cancer	4.39e-05	0.000356	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—prostate cancer	4.38e-05	0.000356	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—prostate cancer	4.36e-05	0.000354	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—prostate cancer	4.36e-05	0.000353	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—prostate cancer	4.34e-05	0.000352	CcSEcCtD
Nicardipine—Tension—Epirubicin—prostate cancer	4.32e-05	0.00035	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—prostate cancer	4.28e-05	0.000347	CcSEcCtD
Nicardipine—Feeling abnormal—Capecitabine—prostate cancer	4.25e-05	0.000345	CcSEcCtD
Nicardipine—Dizziness—Etoposide—prostate cancer	4.24e-05	0.000344	CcSEcCtD
Nicardipine—Gastrointestinal pain—Capecitabine—prostate cancer	4.22e-05	0.000342	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—prostate cancer	4.21e-05	0.000342	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—prostate cancer	4.21e-05	0.000342	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Prednisone—prostate cancer	4.18e-05	0.000339	CcSEcCtD
Nicardipine—Insomnia—Prednisone—prostate cancer	4.15e-05	0.000337	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—prostate cancer	4.15e-05	0.000336	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—prostate cancer	4.12e-05	0.000335	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—prostate cancer	4.08e-05	0.000331	CcSEcCtD
Nicardipine—Abdominal pain—Capecitabine—prostate cancer	4.08e-05	0.000331	CcSEcCtD
Nicardipine—Body temperature increased—Capecitabine—prostate cancer	4.08e-05	0.000331	CcSEcCtD
Nicardipine—Vomiting—Etoposide—prostate cancer	4.07e-05	0.000331	CcSEcCtD
Nicardipine—Agitation—Epirubicin—prostate cancer	4.05e-05	0.000328	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—prostate cancer	4.04e-05	0.000328	CcSEcCtD
Nicardipine—Rash—Etoposide—prostate cancer	4.04e-05	0.000328	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—prostate cancer	4.04e-05	0.000327	CcSEcCtD
Nicardipine—Headache—Etoposide—prostate cancer	4.01e-05	0.000326	CcSEcCtD
Nicardipine—Tension—Doxorubicin—prostate cancer	4e-05	0.000324	CcSEcCtD
Nicardipine—Malaise—Epirubicin—prostate cancer	3.97e-05	0.000322	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—prostate cancer	3.96e-05	0.000321	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—prostate cancer	3.95e-05	0.000321	CcSEcCtD
Nicardipine—Syncope—Epirubicin—prostate cancer	3.95e-05	0.00032	CcSEcCtD
Nicardipine—Constipation—Prednisone—prostate cancer	3.93e-05	0.000319	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—prostate cancer	3.92e-05	0.000318	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—prostate cancer	3.89e-05	0.000316	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—prostate cancer	3.87e-05	0.000314	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—prostate cancer	3.84e-05	0.000311	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—prostate cancer	3.82e-05	0.00031	CcSEcCtD
Nicardipine—Nausea—Etoposide—prostate cancer	3.81e-05	0.000309	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—prostate cancer	3.8e-05	0.000308	CcSEcCtD
Nicardipine—Hypersensitivity—Capecitabine—prostate cancer	3.8e-05	0.000308	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—prostate cancer	3.79e-05	0.000307	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—prostate cancer	3.78e-05	0.000307	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—prostate cancer	3.76e-05	0.000305	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—prostate cancer	3.75e-05	0.000304	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—prostate cancer	3.75e-05	0.000304	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—prostate cancer	3.75e-05	0.000304	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—prostate cancer	3.74e-05	0.000304	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—prostate cancer	3.73e-05	0.000303	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—prostate cancer	3.7e-05	0.0003	CcSEcCtD
Nicardipine—Asthenia—Capecitabine—prostate cancer	3.7e-05	0.0003	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—prostate cancer	3.67e-05	0.000298	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—prostate cancer	3.67e-05	0.000297	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—prostate cancer	3.66e-05	0.000297	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—prostate cancer	3.65e-05	0.000296	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—prostate cancer	3.64e-05	0.000296	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—prostate cancer	3.63e-05	0.000295	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—prostate cancer	3.63e-05	0.000295	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—prostate cancer	3.62e-05	0.000294	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—prostate cancer	3.6e-05	0.000292	CcSEcCtD
Nicardipine—Oedema—Epirubicin—prostate cancer	3.59e-05	0.000291	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—prostate cancer	3.58e-05	0.00029	CcSEcCtD
Nicardipine—Infection—Epirubicin—prostate cancer	3.57e-05	0.000289	CcSEcCtD
Nicardipine—Shock—Epirubicin—prostate cancer	3.53e-05	0.000287	CcSEcCtD
Nicardipine—Diarrhoea—Capecitabine—prostate cancer	3.53e-05	0.000286	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—prostate cancer	3.52e-05	0.000286	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—prostate cancer	3.52e-05	0.000285	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—prostate cancer	3.52e-05	0.000285	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—prostate cancer	3.51e-05	0.000284	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—prostate cancer	3.47e-05	0.000282	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—prostate cancer	3.47e-05	0.000281	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—prostate cancer	3.47e-05	0.000281	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—prostate cancer	3.47e-05	0.000281	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—prostate cancer	3.46e-05	0.00028	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—prostate cancer	3.43e-05	0.000278	CcSEcCtD
Nicardipine—Dizziness—Capecitabine—prostate cancer	3.41e-05	0.000277	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—prostate cancer	3.39e-05	0.000275	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—prostate cancer	3.39e-05	0.000275	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—prostate cancer	3.38e-05	0.000274	CcSEcCtD
Nicardipine—Rash—Docetaxel—prostate cancer	3.36e-05	0.000272	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—prostate cancer	3.36e-05	0.000272	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—prostate cancer	3.36e-05	0.000272	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—prostate cancer	3.35e-05	0.000272	CcSEcCtD
Nicardipine—Headache—Docetaxel—prostate cancer	3.34e-05	0.000271	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—prostate cancer	3.32e-05	0.00027	CcSEcCtD
Nicardipine—Infection—Doxorubicin—prostate cancer	3.3e-05	0.000268	CcSEcCtD
Nicardipine—Asthenia—Prednisone—prostate cancer	3.3e-05	0.000267	CcSEcCtD
Nicardipine—Vomiting—Capecitabine—prostate cancer	3.28e-05	0.000266	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.27e-05	0.000265	CcSEcCtD
Nicardipine—Shock—Doxorubicin—prostate cancer	3.27e-05	0.000265	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—prostate cancer	3.25e-05	0.000264	CcSEcCtD
Nicardipine—Rash—Capecitabine—prostate cancer	3.25e-05	0.000264	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—prostate cancer	3.25e-05	0.000264	CcSEcCtD
Nicardipine—Dermatitis—Capecitabine—prostate cancer	3.25e-05	0.000263	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—prostate cancer	3.24e-05	0.000263	CcSEcCtD
Nicardipine—Headache—Capecitabine—prostate cancer	3.23e-05	0.000262	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—prostate cancer	3.23e-05	0.000262	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—prostate cancer	3.21e-05	0.000261	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—prostate cancer	3.2e-05	0.00026	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—prostate cancer	3.19e-05	0.000259	CcSEcCtD
Nicardipine—Nausea—Docetaxel—prostate cancer	3.16e-05	0.000257	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—prostate cancer	3.16e-05	0.000256	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—prostate cancer	3.14e-05	0.000255	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—prostate cancer	3.11e-05	0.000252	CcSEcCtD
Nicardipine—Pain—Epirubicin—prostate cancer	3.07e-05	0.000249	CcSEcCtD
Nicardipine—Constipation—Epirubicin—prostate cancer	3.07e-05	0.000249	CcSEcCtD
Nicardipine—Nausea—Capecitabine—prostate cancer	3.06e-05	0.000248	CcSEcCtD
Nicardipine—Dizziness—Prednisone—prostate cancer	3.04e-05	0.000246	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.03e-05	0.000246	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—prostate cancer	3.01e-05	0.000244	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—prostate cancer	2.98e-05	0.000242	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—prostate cancer	2.96e-05	0.00024	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—prostate cancer	2.96e-05	0.00024	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—prostate cancer	2.96e-05	0.00024	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—prostate cancer	2.94e-05	0.000238	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—prostate cancer	2.93e-05	0.000237	CcSEcCtD
Nicardipine—Vomiting—Prednisone—prostate cancer	2.92e-05	0.000237	CcSEcCtD
Nicardipine—Rash—Prednisone—prostate cancer	2.9e-05	0.000235	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—prostate cancer	2.89e-05	0.000235	CcSEcCtD
Nicardipine—Headache—Prednisone—prostate cancer	2.88e-05	0.000233	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—prostate cancer	2.84e-05	0.000231	CcSEcCtD
Nicardipine—Pain—Doxorubicin—prostate cancer	2.84e-05	0.000231	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—prostate cancer	2.84e-05	0.00023	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—prostate cancer	2.84e-05	0.00023	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—prostate cancer	2.74e-05	0.000222	CcSEcCtD
Nicardipine—Nausea—Prednisone—prostate cancer	2.73e-05	0.000221	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.72e-05	0.00022	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—prostate cancer	2.65e-05	0.000215	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—prostate cancer	2.63e-05	0.000213	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—prostate cancer	2.63e-05	0.000213	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—prostate cancer	2.58e-05	0.000209	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—prostate cancer	2.46e-05	0.000199	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—prostate cancer	2.45e-05	0.000199	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—prostate cancer	2.38e-05	0.000193	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—prostate cancer	2.38e-05	0.000193	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—prostate cancer	2.28e-05	0.000185	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—prostate cancer	2.27e-05	0.000184	CcSEcCtD
Nicardipine—Rash—Epirubicin—prostate cancer	2.27e-05	0.000184	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—prostate cancer	2.26e-05	0.000184	CcSEcCtD
Nicardipine—Headache—Epirubicin—prostate cancer	2.25e-05	0.000183	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—prostate cancer	2.2e-05	0.000178	CcSEcCtD
Nicardipine—Nausea—Epirubicin—prostate cancer	2.13e-05	0.000173	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—prostate cancer	2.11e-05	0.000171	CcSEcCtD
Nicardipine—Rash—Doxorubicin—prostate cancer	2.1e-05	0.00017	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—prostate cancer	2.09e-05	0.00017	CcSEcCtD
Nicardipine—Headache—Doxorubicin—prostate cancer	2.08e-05	0.000169	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—prostate cancer	1.97e-05	0.00016	CcSEcCtD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	6.14e-07	4.85e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—NOS3—prostate cancer	6.14e-07	4.85e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—prostate cancer	6.12e-07	4.84e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—prostate cancer	6.12e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—prostate cancer	6.1e-07	4.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—prostate cancer	6.1e-07	4.82e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—prostate cancer	6.1e-07	4.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	6.09e-07	4.81e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	6.09e-07	4.81e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	6.09e-07	4.8e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	6.07e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—prostate cancer	6.07e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—prostate cancer	6.07e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—prostate cancer	6.06e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—prostate cancer	6.06e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—prostate cancer	6.06e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—prostate cancer	6.05e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—prostate cancer	6.05e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—EP300—prostate cancer	6.05e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—EP300—prostate cancer	6.04e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—prostate cancer	6.04e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—prostate cancer	6.04e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—prostate cancer	6.03e-07	4.76e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—prostate cancer	6.01e-07	4.75e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—prostate cancer	6.01e-07	4.74e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—prostate cancer	5.99e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—prostate cancer	5.99e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—prostate cancer	5.98e-07	4.72e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—prostate cancer	5.98e-07	4.72e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.98e-07	4.72e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	5.95e-07	4.7e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—prostate cancer	5.95e-07	4.7e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—prostate cancer	5.93e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.93e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—prostate cancer	5.92e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—prostate cancer	5.92e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—prostate cancer	5.9e-07	4.66e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—prostate cancer	5.9e-07	4.66e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—LPL—prostate cancer	5.88e-07	4.64e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—prostate cancer	5.86e-07	4.63e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—prostate cancer	5.86e-07	4.63e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—prostate cancer	5.85e-07	4.62e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—prostate cancer	5.84e-07	4.61e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—prostate cancer	5.82e-07	4.59e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—prostate cancer	5.82e-07	4.59e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—prostate cancer	5.82e-07	4.59e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	5.81e-07	4.58e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—prostate cancer	5.78e-07	4.57e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—prostate cancer	5.78e-07	4.57e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—prostate cancer	5.77e-07	4.55e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—prostate cancer	5.76e-07	4.55e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—prostate cancer	5.75e-07	4.54e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—prostate cancer	5.73e-07	4.52e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	5.71e-07	4.51e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	5.69e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	5.69e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.68e-07	4.48e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—prostate cancer	5.67e-07	4.48e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—prostate cancer	5.67e-07	4.48e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—prostate cancer	5.67e-07	4.47e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—prostate cancer	5.65e-07	4.46e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—prostate cancer	5.65e-07	4.46e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	5.63e-07	4.45e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—prostate cancer	5.63e-07	4.45e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ERCC2—prostate cancer	5.63e-07	4.45e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	5.62e-07	4.44e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—prostate cancer	5.62e-07	4.43e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—prostate cancer	5.61e-07	4.43e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—prostate cancer	5.61e-07	4.43e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—prostate cancer	5.6e-07	4.43e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—prostate cancer	5.6e-07	4.42e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—prostate cancer	5.59e-07	4.42e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—prostate cancer	5.59e-07	4.42e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—prostate cancer	5.58e-07	4.4e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—prostate cancer	5.58e-07	4.4e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—prostate cancer	5.57e-07	4.39e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—prostate cancer	5.57e-07	4.39e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	5.56e-07	4.39e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—prostate cancer	5.54e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—prostate cancer	5.54e-07	4.37e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—prostate cancer	5.53e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—prostate cancer	5.49e-07	4.33e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—prostate cancer	5.48e-07	4.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—prostate cancer	5.46e-07	4.31e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—prostate cancer	5.43e-07	4.29e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—prostate cancer	5.43e-07	4.29e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—prostate cancer	5.42e-07	4.28e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—prostate cancer	5.42e-07	4.28e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—prostate cancer	5.41e-07	4.27e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—prostate cancer	5.4e-07	4.26e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—prostate cancer	5.39e-07	4.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—prostate cancer	5.39e-07	4.26e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	5.38e-07	4.25e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—prostate cancer	5.31e-07	4.2e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—prostate cancer	5.31e-07	4.19e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—prostate cancer	5.3e-07	4.19e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—prostate cancer	5.29e-07	4.18e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—prostate cancer	5.29e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—prostate cancer	5.29e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—prostate cancer	5.29e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—prostate cancer	5.27e-07	4.16e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—prostate cancer	5.27e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—prostate cancer	5.25e-07	4.15e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	5.24e-07	4.14e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—prostate cancer	5.23e-07	4.13e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—prostate cancer	5.23e-07	4.13e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—prostate cancer	5.23e-07	4.13e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—prostate cancer	5.23e-07	4.13e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	5.22e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.21e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARA—prostate cancer	5.19e-07	4.1e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—prostate cancer	5.18e-07	4.09e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—prostate cancer	5.17e-07	4.08e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	5.17e-07	4.08e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—prostate cancer	5.17e-07	4.08e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.17e-07	4.08e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—prostate cancer	5.16e-07	4.08e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	5.16e-07	4.07e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—prostate cancer	5.14e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—prostate cancer	5.14e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—prostate cancer	5.14e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—prostate cancer	5.14e-07	4.06e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—prostate cancer	5.13e-07	4.05e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—prostate cancer	5.13e-07	4.05e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—prostate cancer	5.12e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—prostate cancer	5.12e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—prostate cancer	5.11e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—prostate cancer	5.11e-07	4.04e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—prostate cancer	5.1e-07	4.03e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—prostate cancer	5.1e-07	4.03e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—prostate cancer	5.1e-07	4.02e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—prostate cancer	5.07e-07	4e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	5.06e-07	3.99e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—prostate cancer	5.03e-07	3.97e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—prostate cancer	4.98e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—prostate cancer	4.98e-07	3.93e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	4.94e-07	3.9e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—prostate cancer	4.93e-07	3.89e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—prostate cancer	4.93e-07	3.89e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—prostate cancer	4.9e-07	3.87e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—prostate cancer	4.89e-07	3.86e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—prostate cancer	4.88e-07	3.85e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—prostate cancer	4.86e-07	3.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—prostate cancer	4.86e-07	3.84e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—prostate cancer	4.86e-07	3.84e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—prostate cancer	4.85e-07	3.83e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—prostate cancer	4.84e-07	3.82e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—prostate cancer	4.79e-07	3.78e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—prostate cancer	4.78e-07	3.77e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—prostate cancer	4.78e-07	3.77e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	4.78e-07	3.77e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—prostate cancer	4.76e-07	3.76e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—prostate cancer	4.73e-07	3.74e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—prostate cancer	4.73e-07	3.74e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—prostate cancer	4.72e-07	3.72e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—prostate cancer	4.7e-07	3.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—prostate cancer	4.7e-07	3.71e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—prostate cancer	4.67e-07	3.69e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—prostate cancer	4.61e-07	3.64e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—prostate cancer	4.61e-07	3.64e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.57e-07	3.61e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—prostate cancer	4.56e-07	3.6e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—prostate cancer	4.56e-07	3.6e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—prostate cancer	4.56e-07	3.6e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—prostate cancer	4.55e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—prostate cancer	4.55e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—prostate cancer	4.55e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—prostate cancer	4.55e-07	3.59e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—prostate cancer	4.5e-07	3.56e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.48e-07	3.54e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—prostate cancer	4.47e-07	3.53e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—prostate cancer	4.47e-07	3.53e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	4.46e-07	3.52e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—prostate cancer	4.45e-07	3.51e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.45e-07	3.51e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	4.44e-07	3.51e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	4.4e-07	3.47e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	4.39e-07	3.46e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—prostate cancer	4.38e-07	3.46e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—prostate cancer	4.37e-07	3.45e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—prostate cancer	4.37e-07	3.45e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—prostate cancer	4.34e-07	3.43e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—prostate cancer	4.34e-07	3.43e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—prostate cancer	4.31e-07	3.4e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—prostate cancer	4.3e-07	3.4e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—prostate cancer	4.3e-07	3.4e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—prostate cancer	4.3e-07	3.39e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—prostate cancer	4.3e-07	3.39e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—prostate cancer	4.29e-07	3.38e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—prostate cancer	4.26e-07	3.36e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—prostate cancer	4.26e-07	3.36e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—prostate cancer	4.25e-07	3.35e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—prostate cancer	4.24e-07	3.35e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—prostate cancer	4.24e-07	3.35e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—prostate cancer	4.23e-07	3.34e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—prostate cancer	4.23e-07	3.34e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—INS—prostate cancer	4.21e-07	3.32e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—prostate cancer	4.2e-07	3.31e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—prostate cancer	4.2e-07	3.31e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—prostate cancer	4.15e-07	3.27e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—prostate cancer	4.15e-07	3.27e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.12e-07	3.26e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—prostate cancer	4.05e-07	3.2e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	4.04e-07	3.19e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—prostate cancer	3.95e-07	3.12e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—prostate cancer	3.93e-07	3.11e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—prostate cancer	3.92e-07	3.09e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—prostate cancer	3.92e-07	3.09e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.91e-07	3.09e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—prostate cancer	3.9e-07	3.08e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—prostate cancer	3.89e-07	3.07e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.87e-07	3.06e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—prostate cancer	3.73e-07	2.95e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—prostate cancer	3.72e-07	2.94e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—prostate cancer	3.69e-07	2.91e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—prostate cancer	3.66e-07	2.89e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—prostate cancer	3.65e-07	2.88e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—prostate cancer	3.64e-07	2.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—prostate cancer	3.63e-07	2.87e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—prostate cancer	3.63e-07	2.87e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—prostate cancer	3.6e-07	2.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—prostate cancer	3.6e-07	2.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—prostate cancer	3.6e-07	2.84e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—prostate cancer	3.59e-07	2.84e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	3.58e-07	2.83e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—prostate cancer	3.52e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—prostate cancer	3.52e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—prostate cancer	3.48e-07	2.75e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—prostate cancer	3.48e-07	2.75e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.45e-07	2.73e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.41e-07	2.69e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.38e-07	2.67e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.37e-07	2.66e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—prostate cancer	3.29e-07	2.6e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—prostate cancer	3.19e-07	2.52e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—prostate cancer	3.19e-07	2.52e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.18e-07	2.51e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—prostate cancer	3.16e-07	2.5e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.15e-07	2.49e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—prostate cancer	3.04e-07	2.4e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—prostate cancer	2.94e-07	2.32e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—prostate cancer	2.94e-07	2.32e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—prostate cancer	2.94e-07	2.32e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—prostate cancer	2.82e-07	2.23e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—prostate cancer	2.81e-07	2.22e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—prostate cancer	2.75e-07	2.17e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—prostate cancer	2.6e-07	2.05e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—prostate cancer	2.57e-07	2.03e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.08e-07	1.64e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—prostate cancer	1.7e-07	1.34e-06	CbGpPWpGaD
